CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts Price Target on Ardelyx to $9 From $19, Maintains Outperform Rating

Negative
AI Analysis

Summary

Wedbush reduced its price target on Ardelyx from $19 to $9 while maintaining an Outperform rating, representing a significant downward revision of analyst expectations.

Importance:2/10
Sentiment:
-0.70
price_target_reductionanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 7, 2026 1:49 PM

Read Original